Web Results

Miglustat

en.wikipedia.org/wiki/Miglustat

Miglustat (OGT 918, N-butyl-deoxynojirimycin) is a drug developed by Oxford GlycoSciences and marketed by Actelion and is used primarily to treat type I ...

Miglustat for treatment of Niemann-Pick C disease: a ... - NCBI

www.ncbi.nlm.nih.gov/pubmed/17689147

Lancet Neurol. 2007 Sep;6(9):765-72. Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. Patterson MC(1), Vecchio D, Prady H, ...

Zavesca (miglustat

www.zavesca.com/

Zavesca, INN- Miglustat - Actelion

www1.actelion.com/documents/corporate/smpc-pils/zavesca-smpc.pdf

Each capsule contains 100 mg miglustat. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM. Hard capsule. White capsules with “OGT ...

DrugBank: Miglustat

www.drugbank.ca/drugs/DB00419

Jun 13, 2005 ... Miglustat is a drug used to treat Gaucher disease. It inhibits the enzyme glucosylceramide synthase, an essential enzyme for the synthesis of ...

Zavesca, INN- Miglustat - European Medicines Agency - Europa.eu

www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000435/WC500046726.pdf

Each capsule contains 100 mg miglustat. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM. Hard capsule. White capsules with “OGT ...

Miglustat: Indications, Side Effects, Warnings - Drugs.com

www.drugs.com/cdi/miglustat.html

Easy to read patient leaflet for miglustat. Includes indications, proper use, special instructions, precautions, and possible side effects.

Zavesca (miglustat) Uses, Dosage, Side Effects - Drugs.com

www.drugs.com/zavesca.html

Zavesca (miglustat) reduces the formation of a certain protein in the body in people with type 1 Gaucher disease. Gaucher disease is a genetic condition in ...

package insert - FDA

www.accessdata.fda.gov/drugsatfda_docs/label/2010/021348s008lbl.pdf

is supplied in hard gelatin capsules each containing 100 mg miglustat for oral administration. Each ZAVESCA. ®. 100 mg capsule also contains sodium starch.

Zavesca (miglustat) dosing, indications, interactions, adverse effects ...

reference.medscape.com/drug/zavesca-miglustat-342874

Medscape - Indication-specific dosing for Zavesca (miglustat), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy ...

More Info

Miglustat: MedlinePlus Drug Information - National Library of Medicine

www.nlm.nih.gov

Miglustat is used to treat Gaucher's disease (a condition in which a certain fatty substance is not broken down normally in the body and instead builds up in ...

Zavesca - Actelion

www1.actelion.com

The usual dose of Zavesca® in adult NP-C patients was 200 mg miglustat three times a day, and was adjusted according to body surface area in pediatric NP-C ...

Zavesca (Miglustat) Drug Information: Description, User Reviews ...

www.rxlist.com

Zavesca (miglustat capsules, 100 mg) is an inhibitor of the enzyme glucosylceramide synthase, which is a glucosyl transferase enzyme responsible for the first ...